Sienaert Pascal, Peuskens Joseph
ECT Department and Department of Mood Disorders, University Centre Sint-Josef, Katholieke Universiteit Leuven, Kortenberg, Belgium.
Bipolar Disord. 2006 Jun;8(3):304-6. doi: 10.1111/j.1399-5618.2006.00317.x.
We report our experience with a medication-refractory patient with bipolar I disorder, who remained clinically stable under continuation electroconvulsive therapy (C-ECT). We found ECT to be effective in providing functionality for a patient when various medications had failed.
A 53-year-old woman with a 31-year history of recurrent manic and depressive episodes poorly responsive to medications warranted an ECT trial. Remission was achieved after 12 treatments and C-ECT at weekly intervals was used as maintenance therapy. C-ECT was continued for 37 months and 85 treatments, and discontinued when anesthetic difficulties precluded further treatment. Three months after the last ECT, she was readmitted in a severe manic relapse. Restarting ECT caused rapid remission. There are no signs of cognitive deterioration during C-ECT.
Long-term C-ECT is an effective and safe prophylactic treatment in individual treatment-resistant patients with bipolar disorder.
我们报告了一位对药物治疗无效的双相I型障碍患者的治疗经历,该患者在继续性电休克治疗(C-ECT)下保持临床稳定。我们发现,当各种药物治疗均告失败时,电休克治疗能有效地为患者提供功能改善。
一名53岁女性,有31年复发性躁狂和抑郁发作病史,对药物反应不佳,因此接受了电休克治疗试验。经过12次治疗后病情缓解,随后以每周一次的频率进行C-ECT作为维持治疗。C-ECT持续了37个月,共进行了85次治疗,因麻醉困难无法继续治疗而停药。最后一次电休克治疗三个月后,她因严重躁狂复发再次入院。重新开始电休克治疗后病情迅速缓解。在C-ECT期间没有认知功能恶化的迹象。
长期C-ECT对于个别难治性双相情感障碍患者是一种有效且安全的预防性治疗方法。